Matches in SemOpenAlex for { <https://semopenalex.org/work/W2413251702> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W2413251702 endingPage "7" @default.
- W2413251702 startingPage "43" @default.
- W2413251702 abstract "In Poland diagnosing of hypertension (HA) and the efficacy of treatment of this condition is still insufficient. Consideration of the concomitant metabolic disorders may help to choose the best line of therapy.To determine the incidence of HA and concomitant lipid and carbohydrate metabolism disturbances in population of one company. To assess the efficacy of monotherapy of HA and the influence of therapy on some metabolic parameters.The blood pressure was measured in 599 subjects. Patients with HA (> or = 140/90 mmHg) were treated according to metabolic parameters. Patients with fasting total cholesterol (TC) > or = 200 mg% and/or fasting glucose level > or = 110 mg% received doxazosin (D); initial dose 1 mg. The remaining patients received amlodipine (A); initial dose 5 mg.HA was found in 154 patients (27.5%). In this group, 50 of subjects were unaware of the disease, the remaining 67 (44%) were not treated or treated insufficiently. Elevated glucose and/or TC levels were found in 51% of hypertensives. After one month of treatment with A or D, the mean systolic and diastolic blood pressure decreased significantly (p = 0.001). Monotherapy was effective in 88.9% of subjects in group D and in 92.1% in group A. In group D, TC concentration decreased by 9.5% comparing to baseline (p = 0.001). The tolerance of treatment was similar in both groups.One fourth of the examined company population under medical attention of the local health service had HA. One third of HA patients were unaware of the disease. The half of patients with HA had metabolic disorders. Doxazosin and amlodipine were equally effective and well tolerated during one month of treatment. Treatment with doxazosin positively influenced the metabolic profile." @default.
- W2413251702 created "2016-06-24" @default.
- W2413251702 creator A5013171338 @default.
- W2413251702 creator A5037355910 @default.
- W2413251702 date "2002-07-01" @default.
- W2413251702 modified "2023-09-23" @default.
- W2413251702 title "[Hypertension and metabolic syndrome in population of one company. Monotherapy with amlodipine and doxazosin]." @default.
- W2413251702 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12362505" @default.
- W2413251702 hasPublicationYear "2002" @default.
- W2413251702 type Work @default.
- W2413251702 sameAs 2413251702 @default.
- W2413251702 citedByCount "0" @default.
- W2413251702 crossrefType "journal-article" @default.
- W2413251702 hasAuthorship W2413251702A5013171338 @default.
- W2413251702 hasAuthorship W2413251702A5037355910 @default.
- W2413251702 hasConcept C120665830 @default.
- W2413251702 hasConcept C121332964 @default.
- W2413251702 hasConcept C126322002 @default.
- W2413251702 hasConcept C134018914 @default.
- W2413251702 hasConcept C2777590997 @default.
- W2413251702 hasConcept C2779384505 @default.
- W2413251702 hasConcept C2779646130 @default.
- W2413251702 hasConcept C2780578515 @default.
- W2413251702 hasConcept C2908647359 @default.
- W2413251702 hasConcept C511355011 @default.
- W2413251702 hasConcept C57900726 @default.
- W2413251702 hasConcept C61511704 @default.
- W2413251702 hasConcept C71924100 @default.
- W2413251702 hasConcept C84393581 @default.
- W2413251702 hasConcept C90924648 @default.
- W2413251702 hasConcept C99454951 @default.
- W2413251702 hasConceptScore W2413251702C120665830 @default.
- W2413251702 hasConceptScore W2413251702C121332964 @default.
- W2413251702 hasConceptScore W2413251702C126322002 @default.
- W2413251702 hasConceptScore W2413251702C134018914 @default.
- W2413251702 hasConceptScore W2413251702C2777590997 @default.
- W2413251702 hasConceptScore W2413251702C2779384505 @default.
- W2413251702 hasConceptScore W2413251702C2779646130 @default.
- W2413251702 hasConceptScore W2413251702C2780578515 @default.
- W2413251702 hasConceptScore W2413251702C2908647359 @default.
- W2413251702 hasConceptScore W2413251702C511355011 @default.
- W2413251702 hasConceptScore W2413251702C57900726 @default.
- W2413251702 hasConceptScore W2413251702C61511704 @default.
- W2413251702 hasConceptScore W2413251702C71924100 @default.
- W2413251702 hasConceptScore W2413251702C84393581 @default.
- W2413251702 hasConceptScore W2413251702C90924648 @default.
- W2413251702 hasConceptScore W2413251702C99454951 @default.
- W2413251702 hasIssue "73" @default.
- W2413251702 hasLocation W24132517021 @default.
- W2413251702 hasOpenAccess W2413251702 @default.
- W2413251702 hasPrimaryLocation W24132517021 @default.
- W2413251702 hasRelatedWork W1965940059 @default.
- W2413251702 hasRelatedWork W2000630045 @default.
- W2413251702 hasRelatedWork W2026881792 @default.
- W2413251702 hasRelatedWork W2029290222 @default.
- W2413251702 hasRelatedWork W2048583251 @default.
- W2413251702 hasRelatedWork W2231388175 @default.
- W2413251702 hasRelatedWork W2397043479 @default.
- W2413251702 hasRelatedWork W2413251702 @default.
- W2413251702 hasRelatedWork W2748694806 @default.
- W2413251702 hasRelatedWork W2801161412 @default.
- W2413251702 hasVolume "13" @default.
- W2413251702 isParatext "false" @default.
- W2413251702 isRetracted "false" @default.
- W2413251702 magId "2413251702" @default.
- W2413251702 workType "article" @default.